Cardiovascular-Diseases
Cardio-Oncology: Practical Solutions to Advance Your Practice
This course provides practical knowledge and skills concerning the management of cardiac and vascular diseases affecting patients with cancer and cancer survivors. Through interactive, practice-based case presentations and lectures by leading practitioners in the field, participants will learn the most recent and topical developments in this emerging field. It will cover common cardiovascular complications, such as heart failure (HF), myocardial ischemia, hypertension (HTN), thromboembolism, Arrhythmia associated with frequently used anticancer medications. The goal is to improve quality, safety and outcomes for patients within the dynamic and interactive educational experience.
|
Target Audience
This course is designed for clinical cardiologists, heart failure specialists, oncologists, hematologists, internal medicine specialists, nurse practitioners, physician assistants, and allied health personnel working in cardiology or hematology-oncology areas
Learning Objectives
Upon conclusion of this program, participants should be able to:
- Understand the chemotherapeutic agents most commonly associated with cardiovascular risk.
- Diagnose the unique aspects of cardiovascular diseases associated with cancer and cancer therapy, including cardiomyopathies, myocarditis, pericarditis, amyloidosis, vascular disease, and cardiac masses.
- Improve patient outcomes by developing an approach to the complexities of managing cancer patients with cardiovascular disease through case based learning.
To learn more about bringing the Cardiovascular-Disease Programs to your university, and how it helps executives drive real business results, contact us at 1.844.669.7884 to speak with a program counselor.
Offer your executive clients top programs and best-in-class curriculum with Zschool |
Become a Zschool Partner
Learn about Zschool partnership opportunities with the various programs designed to enhance your institution’s enrollment and profitability.